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Abstract We have used a modification of the footprinting tech- 
nique to measure the dissociation of mithramycin, echinomycin 
and nogalamycin from their binding sites in a natural DNA frag- 
ment. Complexes with radiolabelled DNA were dissociated by 
addition of unlabelled DNA. Samples were removed at various 
times and subjected to DNase I digestion, and the rate of dissoci- 
ation from each site was estimated from the time-dependent dis- 
appearance of the footprints. For echinomycin the slowest rate 
of dissociation is from ACGT, while the slowest site for mithra- 
mycin contains four contiguous guanines. The dissociation of 
nogalamycin is extremely slow, even from its weaker sites; the 
slowest rate was from ACGTA, which took longer than 4 h, even 
at 37 ° C. 
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that the complexity observed with natural DNA is due to the 
parallel dissociation from different binding sites, each of which 
has different microscopic kinetic constants. 
We have recently developed a modification of the foot- 
printing technique [20] for visualising the dissociation of ligands 
from individual binding sites in a mixed sequence DNA. In this 
technique a complex between the ligand and radiolabelled 
DNA is dissociated by addition of excess unlabelled DNA. 
Samples are removed from the reaction mixture at various 
times and subjected to DNase I footprinting. Dissociation from 
each binding site is visualised as the time-dependent disappear- 
ance of the footprint. In this paper we use this technique to 
examine the dissociation of echinomycin, mithramycin and 
nogalamycin from tyrT DNA, and obtain the first estimates for 
the dissociation of these ligands from individual binding sites. 
2. Materials and methods 
I. Introduction 
Echinomycin, mithramycin and nogalamycin are antitumour 
agents which are thought o act by virtue of their ability to bind 
to DNA [1]. Echinomycin is a bifunctional intercalator, which 
is selective for the dinucleotide CpG [2 5]. Mithramycin binds 
as a dimer within the DNA minor groove [5,6] and is selective 
for GC-rich regions of DNA [7-9]. Nogalamycin is an unusual 
anthracycline antibiotic, possessing bulky groups at both ends 
of its chromophore, which binds by intercalation, spearing be- 
tween the DNA base pairs [10 12]. Since it requires local dis- 
ruption of DNA duplex before it can bind, it has very slow 
kinetic parameters [13,14], and binds fastest o regions which 
are easiest o disrupt, such as poly(dA-dT) [13]. It binds espe- 
cially well to regions containing alternating purines and pyri- 
midines, especially TGC [15,16]. 
It has been suggested that, for a series of related compounds, 
there is a correlation between their biological activity and their 
persistence time on the DNA lattice. Each of these ligands is 
known to dissociate slowly from DNA with half-lives of several 
minutes. The dissociation rates have typically been measured 
by SDS sequestration techniques, in which a complex between 
the ligand and DNA is dissociated by adding SDS to sequester 
the free ligand as it dissociates from the DNA. For echinomycin 
[17,18], nogalamycin [13,14] and mithramycin [19] the dissocia- 
tion from mixed sequence DNAs is a complex function requir- 
ing several exponentials for its complete description. In con- 
trast the dissociation of echinomycin and nogalamycin from 
synthetic DNAs is described by a single exponential, suggesting 
*Corresponding author. Fax: (44)(1703) 59-4319. 
2.1. Drugs and enzymes 
Echinomycin was obtained from the National Cancer Institute USA 
and stored at 4°C as a stock solution of 1 mM in dimethylsulphoxide. 
Mithramycin was a gift from Pfizer Inc. USA and was stored at -20°C 
as a stock solution of 1 mM in 10 mM Tris-HCl pH 8.0, containing 10 
mM NaCI. Nogalamycin was a gift from Dr. P.F. Wiley, Upjohn Co., 
Kalamazoo. DNase I was purchased from Sigma and stored at -20°C 
at a concentration f 7200 units/ml. All other enzymes were purchased 
from Promega. [c~-nP]dATP (3000 Ci/mmol) was purchased from 
Amersham. 
2.2. DNA fragments 
The tyrT DNA fragment (Fig. 1) was prepared as previously de- 
scribed [2,8,15], by cutting with EeoRI and AvaI, and was labelled at 
the Y-end of the EeoR1 site with [~-nP]dATP using reverse transcript° 
ase. The radiolabelled fragment was separated from the remainder of 
the plasmid on a 6% (w/v) polyacrylamide g l. 
2.3. DNase I footprinting 
Samples for footprinting were prepared by mixing 9/.tl of radiola- 
belled DNA (about 50 pmol base pairs) with 9 ~1 of ligand, dissolved 
in 10 mM Tris-HC1 pH 8.0, containing 10 mM EDTA, at the concentra- 
tion described in the text. This mixture was left to equilibrate for at least 
30 min. Dissociation of the antibiotic was initiated by adding 10/ll calf 
thymus DNA (3 mM base pairs). 4/~1 aliquots were removed from this 
mixture at various times and digested with 2 ¢tl DNase I (150 units/ml 
dissolved in 2 mM MgCI2, 2 mM MnCI2, 20 mM NaC1). The reaction 
AATTCCGGTTACCTTTAATCCGTTACGGATGAAAATTACGCAACCAGTTCATTTTTCTCAACGTAACAC 
0 i0 20 30 40 50 60 
3 ' -AAGGCCAATGGAAATTAGGCAATGCCTACTTTTAATGCGTTGGTCAAGTAAAAAGAGTTGCATTGTG 
TTTACAGCGGCGCGTCATTTGATATGATGCGCCCCGCTTCCCGATAAGGGAGCAGGCCAGTAAAAAGCATT 




TGGGGCACCACCCCCAAGGGCT-5 '  
Fig. 1. Sequence of the tyrT DNA fragment. 
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Fig. 2. Dissociation of mithramycin and echinomycin from tyrT DNA at 20°C. Aliquots were removed from mixtures of radiolabelled tyrT DNA 
and mithramycin (50/~M) or echinomycin (20 BM) at various times after adding unlabelled calf thymus DNA and subjected to short (12 s) digestion 
by DNase I. The time after adding the competitor DNA (minutes) is indicated at the top of each lane. 'con' indicates digestion of the DNA alone 
in the absence of any ligand; '0' corresponds to digestion of a complex with the ligands before adding the unlabelled DNA. In the track labelled 'Eq' 
the labelled and unlabelled DNA were mixed before adding the ligand, and represents he true equilibrium distribution of the ligand in the dissociating 
mixture. The track labelled 'GA' is a Maxam-Gilbert marker specific for purines. The numbers correspond to the sequence shown in Fig. 1. 
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Fig. 3. Dissociation of nogalamycin from tyrT DNA measured at 20°C and 37°C. Aliquots were removed from complexes of radiolabelled tyrT DNA 
with nogalamycin (3/zM) at various times after adding unlabelled calf thymus DNA and subjected to short (12 s) digestion by DNase I. The time 
after adding the competitor DNA (minutes) is indicated at the top of each lane. 'con' indicates digestion of the DNA alone in the absence of any 
ligand; '0' corresponds to digestion of a complex with the ligands+ before adding the unlabelled DNA. In the track labelled 'Eq' the labelled and 
unlabelled DNA were mixed before adding the drug, and represents he true equilibrium distribution of the ligand in the dissociating mixture. The 
track labelled 'GA' is a Maxam-Gilbert marker specific for purines. The numbers correspond to the sequence shown in Fig. 1. 
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was stopped after 12 s by addition of4gtl formamide containing 10 mM 
EDTA and 0.1% (w/v) bromophenol b ue. The footprinting pattern at 
equilibrium was determined by mixing the radiolabelled and unlabelled 
DNA before adding the antibiotics and digesting in the same manner. 
Digestion patterns of the native DNA and the complex before dissoci- 
ation were obtained in the usual manner by mixing 1.5/~1 radiolabelled 
DNA with 2/11 drug and digesting for 1 min with 2/~1 DNase I (0.03 
units/ml). 
2.4. Gel electrophoresis 
All samples were heated to 95°C for 3 min prior to electrophoresis. 
The products of digestion were resolved on 8% (w/v) polyacrylamide 
gels containing 8M urea. Gels were run at 1500 V for about 2 h. These 
were fixed in 10% acetic acid, transferred toWhatmann 3MM paper, 
dried under vacuum at 80°C and subjected to autoradiography at 
-70°C with an intensifying screen. Bands in the digests were assigned 
by comparison with Maxam-Gilbert markers pecific for guanine and 
adenine. 
3. Results and discussion 
3.1. Mithramyc#~ 
Fig. 2 shows DNase I footprinting profiles for the dissocia- 
tion of mithramycin from tyrT DNA. Three clear DNase I 
footprints are evident in the 'time 0' lane, as previously reported 
[8,9], between positions 35~,0, 65-78 and 91 122. Each of these 
is located in a GC-rich region and the latter two contain several 
overlapping ligand binding sites. It can be seen that, on adding 
the competitor DNA, each of these footprints disappears in a 
time-dependent fashion, which is not the same for each site. 
Looking first at the top site (91-122) it can be seen that the 
uppermost bands around position 115 120 return to the con- 
trol pattern by the first time point suggesting that dissociation 
from GGCC (121) and CCC (113) is relatively fast; this was also 
too fast to measure at 4°C (not shown). Dissociation from 
106 112 (presumably corresponding to binding at the CGGG 
located at position 106) is a little slower; bands in this region 
still show attenuated cleavage after 0.5 min but not 1 rain. In 
contrast dissociation from around position 100 (within the se- 
quence GCGGGGCGC) is much slower, and bands only begin 
to reappear 5 min after adding the competitor DNA. Dissocia- 
tion from the middle footprint (65 78, which contains three 
overlapping mithramycin binding sites [9]) also shows an inter- 
mediate rate and is complete by 1 min. Similar experiments 
performed at 4°C (not shown) suggested that dissociation from 
the top of this footprint was slower than from the bottom. 
Dissociation from the lowest site (3540) is also relatively fast 
and is largely complete by the first time point. This region 
contains only two GC residues (GpG) and is a much poorer 
binding site. 
These data confirm that the dissociation of mithramycin 
from its GC binding sites is relatively slow and that the disso- 
ciation time constants from different sites vary between 
0.5 5 min. The longest rates are observed from the uninter- 
rupted stretch of GC residues around position 100, and proba- 
bly result from the slow dissociation from GGGG. Several 
regions of enhanced DNase I cleavage are apparent in the 'time 
0' lane (especially around positions 80-90 and 123 125). These 
are no longer apparent by the first time point, suggesting that 
they arise from changes in the ratio of free DNA to enzyme in 
the presence of the drug [21], and are not caused by drug- 
induced changes in DNA structure, since the latter should dis- 
appear at a similar rate to the footprints. 
3.2. Ech&omycin 
Fig. 2 also shows the time course for the dissociation of 
echinomycin from tyrT DNA. The fragment contains 8echino- 
mycin binding sites (CpG) between positions 25 110, each of 
which has been shown to yield clear DNase I footprints [2]. The 
top three CpG sites (CCGA, CCGC and GCGC) overlap to 
produce a single DNase I footprint. Dissociation from this 
region is complete by 5 min. The next footprint down (68-82) 
also contains three overlapping echinomycin binding sites 
(GCGT, GCGC and GCGG). Bands in the lower portion of 
this footprint reappear sooner than those in the upper region, 
suggesting that GCGG may be a poorer echinomycin binding 
site than GCGT or GCGC. The footprint around position 60 
contains an isolated echinomycin binding site ACGT; dissocia- 
tion from this site takes about 30 min, slower than from any 
of the other sites on this fragment. Another isolated CpG site 
is responsible for the footprint seen around position 37 
(ACGC). Dissociation from this site is relatively fast (about 5 
rain) even though it represents only a single base change from 
the next site up. Once again several regions of enhanced DNase 
I cleavage are apparent in the 'time 0' lane, which have disap- 
peared by the first time point. Their rapid removal suggests that 
they are not caused by drug-induced changes in DNA structure. 
Based on these results it appears that echinomycin dissoci- 
ates most slowly from ACGT, requiring about 30 min for the 
footprint to disappear, compared with dissociation from 
GCGG which is complete within 1 min. 
3.3, Nogalamycin 
Fig. 3 shows the dissociation of3ctM nogalamycin from tyrT 
DNA. This ligand does not have an absolute sequence binding 
preference, binding best to regions of alternating purines and 
pyrimidines [15,16]; it therefore causes a general decrease in 
DNase I cleavage throughout a large part of the fragment, 
which makes the dissociation profiles difficult to interpret. 
Since the dissociation is extremely slow at 20°C we have re- 
peated the experiments at37°C to obtain a clearer estimate of 
the different relative dissociation times. The region between 
80-105 contains a good nogalamycin binding site (ATGCG) 
around position 94 [15]. The ligand dissociates from the upper 
part of this region with a time constant of about 20 h at 20°C, 
compared with bands in the lower part of this footprint which 
reappear after only about 60 min. Most of the remainder of the 
fragment shows a single large protection which persists for 
most of the 24 h time course at 20°C. Exceptions to this are the 
bands at positions 41, 60 and 61 which have returned by 20 h. 
Clearer information about he dissociation from this region can 
be obtained by examining the footprinting patterns obtained at 
37°C. For most of the region below position 80 the cleavage 
pattern has returned to that in the control by 120 min after 
adding the competitor DNA. As noted at 20°C the bands at 41, 
60 and 61 return the fastest. Bands around position 57 (corre- 
sponding to ligand binding to the sequence ACGTA [15]), only 
begin to reappear after 120 min and cleavage in this region has 
not returned to that in the control even at the longest time point 
(4 h). 
These results demonstrate that the dissociation of nogalamy- 
cin is extremely slow. This takes up to 30 rain at 37°C from its 
weaker binding sites, and requires longer than 4 h at the opti- 
mum binding sites. 
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